BioSpace News Archive

Biotech Beach

Biocept Announces Pricing of $15M Public Offering of 33,333,333 Shares of Common Stock and Warrants to Purchase 33,333,333 Shares of Common Stock

The warrants will have a per share exercise price of $0.50, are exercisable immediately and will expire five years from the date of issuance.

January 26, 2018
·
4 min read
Job Trends

GSK Announces CHMP Positive Opinion for Labelling Update to Relvar Ellipta in Patients with Asthma

GlaxoSmithKline plc and Innoviva, Inc. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending a label update for the use of once-daily Relvar Ellipta.

January 26, 2018
·
18 min read
Business

Hill-Rom Exceeds Guidance With Strong Fiscal First Quarter Financial Results

For the fiscal first quarter, Hill-Rom reported earnings of $1.31 per diluted share compared to $0.36 per diluted share in the prior-year period.

January 26, 2018
·
34 min read
Business

Hill-Rom CEO to Retire, Hunt for Successor Begins

At the effective time of the retirement, Mr. Greisch will also step down from the board of directors of the company.

January 26, 2018
·
3 min read
Drug Development

AstraZeneca’s Three-in-One COPD Inhaler Succeeds in Phase III Trial

Astra has Glaxo and its COPD treatment Trelegy Ellipta squarely in its sights.

January 26, 2018
·
2 min read
BioAmber Restructures its Credit Facility With its Senior Lenders

This amendment to the loan agreement removes certain financial covenants under the terms of the loan agreement with the senior lenders, namely a minimum cash requirement and ongoing revenue covenants.

January 26, 2018
·
2 min read
Business

ImmunoGen Announces Conference Call to Discuss Its 2017 Operating Results

ImmunoGen today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, February 9, 2018 to discuss its 2017 operating results.

January 26, 2018
·
1 min read
Business

InVivo Therapeutics Announces Purchase Agreement for up to $15 Million with Lincoln Park Capital

In consideration for entering into the purchase agreement, the company has issued shares of common stock to Lincoln Park as a commitment fee. The purchase agreement may be terminated by the company at any time, in its sole discretion.

January 26, 2018
·
4 min read
Business

Teligent Announces the Appointment of Damian Finio as CFO

Mr. Finio has held numerous senior financial roles in the healthcare industry, including nearly fourteen years at AstraZeneca Pharmaceuticals.

January 26, 2018
·
2 min read
Hemispherx Announces Presentation on the Potential Role of Ampligen as an Immune System Amplifier Improving Seasonal Flu Vaccine Cross-Protection

Data will be reviewed on January 30, 2018 at the Keystone Symposia Conference on Emerging Technologies in Vaccine Discovery and Development.

January 26, 2018
·
2 min read